紅麴文獻薈萃報告 — 2026 年 2 月

摘要

本月共收錄 紅麴 相關文獻 171 篇,其中 Level 1 證據(Meta-Analysis/Systematic Review)11 篇,RCT 11 篇。

證據等級分布

證據等級 文獻數 佔比
Level 1 (Meta-Analysis/Systematic Review) 11 6.4%
Level 2 (RCT) 11 6.4%
Level 3 (Clinical Trial) 2 1.2%
Level 4 (Observational) 1 0.6%
Level 5 (Review/Case Report/Other) 146 85.4%

功效分類統計

功效分類 中文 文獻數 佔比
cardiovascular 心血管 154 90.1%
metabolic 代謝 43 25.1%
immune 免疫調節 19 11.1%
musculoskeletal 肌肉骨骼 14 8.2%
digestive 消化 14 8.2%
other 其他 14 8.2%
anti_aging 抗衰老 8 4.7%
energy 活力 4 2.3%
cognitive 認知功能 2 1.2%
sexual 性功能 1 0.6%

成分搭配統計

成分 文獻數
NAC 68
EPA 36
berberine 18
garlic 8
coenzyme Q10 5
fiber 5
creatine 4
omega-3 4
astaxanthin 3
glutathione 3

成分組合分析

以下列出最常被共同研究的成分組合:

成分組合 共同出現文獻數
EPA + NAC 19
NAC + berberine 6
berberine + garlic 5
berberine + fiber 4
NAC + glutathione 3
NAC + coenzyme Q10 3
fiber + garlic 3
berberine + green tea 3
garlic + green tea 3
cinnamon + garlic 3

成分功效分析

以下列出主要成分在各功效領域的研究文獻數:

成分 總文獻 心血管 代謝 免疫調節 消化 肌肉骨骼 抗衰老
NAC 68 62 9 9 5 6 2
EPA 36 36 12 6 5 4 2
berberine 18 18 6 - 2 2 1
garlic 8 8 1 1 1 1 1
coenzyme Q10 5 4 1 1 - - -
fiber 5 5 1 - 2 - 1

研究類型分布

研究類型 文獻數 佔比
Meta-Analysis 9 5.3%
Systematic Review 2 1.2%
RCT 11 6.4%
Clinical Trial 2 1.2%
Observational 1 0.6%
Review 26 15.2%
Case Report 11 6.4%
Other 109 63.7%

近期重要文獻

Level 1 證據(Meta-Analysis / Systematic Review)

  1. Effectiveness of red yeast rice on carotid atherosclerosis: A systematic review and meta-analysis. — Frontiers in pharmacology, 2022-01-01
    • 功效分類:cardiovascular
  2. Effects of the combination of red yeast rice-containing commercial Chinese polyherbal preparation with statins for dyslipidemia: a systematic review and meta-analysis. — Frontiers in pharmacology, 2024-01-01
    • 功效分類:cardiovascular
  3. A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults. — Pharmacological research, 2022-09-01
    • 功效分類:cardiovascular, musculoskeletal
  4. Comparing the effectiveness of Chinese patent medicines containing red yeast rice on hyperlipidaemia: A network meta-analysis of randomized controlled trials. — Endocrinology, diabetes & metabolism, 2022-01-01
    • 功效分類:cardiovascular
  5. Monacolin K supplementation in patients with hypercholesterolemia: A systematic review of clinical trials. — Semergen, 2024-01-01
    • 功效分類:cardiovascular

Level 2 證據(RCT)

  1. Efficacy of AI-Guided (GenAIS — Nutrients, 2024-06-26
    • 功效分類:cardiovascular, metabolic
  2. Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trial. — Cardiovascular diabetology, 2025-10-03
    • 功效分類:cardiovascular, metabolic
  3. Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trial. — Asia Pacific journal of clinical nutrition, 2021-09-01
    • 功效分類:cardiovascular, musculoskeletal
  4. Efficacy of Food Supplement Based on Monacolins, γ-Oryzanol, and γ-Aminobutyric Acid in Mild Dyslipidemia: A Randomized, Double-Blind, Parallel-Armed, Placebo-Controlled Clinical Trial. — Nutrients, 2024-09-04
    • 功效分類:cardiovascular
  5. Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia. — Nutrients, 2022-07-08
    • 功效分類:cardiovascular, immune

Copyright © 2026 保健食品產品情報系統